{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["132(8)"],"submitter":["Li GX"],"pubmed_abstract":["<h4>Background</h4>PI3K pathway activation is a common and early event in prostate cancer, from loss of function mutations in PTEN, or activating mutations in PIK3Ca or AKT leading to constitutive activation, induction of growth factor-receptors kinase EphB4 and its ligand ephrin-B2. We hypothesized that induction of EphB4 is an early event required for tumor initiation. Secondly, we hypothesized that EphB4 remains relevant when prostate cancer becomes androgen independent.<h4>Methods</h4>Genetic mouse model of conditional PTEN deletion in prostate epithelium induces tumor in all mice. We tested this model against EPHB4 wild type and deleted in prostate epithelium. This allowed us to test its role in tumor initiation. We also tested an orthogonal approach by using decoy soluble EphB4 to bl"],"journal":["British journal of cancer"],"pagination":["679-689"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11997055"],"repository":["biostudies-literature"],"pubmed_title":["EphB4-ephrin-B2 are targets in castration resistant prostate cancer."],"pmcid":["PMC11997055"],"pubmed_authors":["Salhia B","Siddiqi IN","Ma B","Gross M","Sali A","Liu R","Sadeghi S","Li GX","Gill PS","Zhang S","El-Khoueiry A"],"additional_accession":[]},"is_claimable":false,"name":"EphB4-ephrin-B2 are targets in castration resistant prostate cancer.","description":"<h4>Background</h4>PI3K pathway activation is a common and early event in prostate cancer, from loss of function mutations in PTEN, or activating mutations in PIK3Ca or AKT leading to constitutive activation, induction of growth factor-receptors kinase EphB4 and its ligand ephrin-B2. We hypothesized that induction of EphB4 is an early event required for tumor initiation. Secondly, we hypothesized that EphB4 remains relevant when prostate cancer becomes androgen independent.<h4>Methods</h4>Genetic mouse model of conditional PTEN deletion in prostate epithelium induces tumor in all mice. We tested this model against EPHB4 wild type and deleted in prostate epithelium. This allowed us to test its role in tumor initiation. We also tested an orthogonal approach by using decoy soluble EphB4 to bl","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 May","modification":"2025-07-10T03:08:23.196Z","creation":"2025-07-10T03:08:23.196Z"},"accession":"S-EPMC11997055","cross_references":{"pubmed":["40044981"],"doi":["10.1038/s41416-025-02942-5"]}}